Clinical efficacy of double dose valsartan on hypertension complicated with microalbuminuria in elderly

jin jun,zhang zhen,cui liang,zhao zhe,tan shijin

DOI: https://doi.org/10.3969/j.issn.1003-9198.2015.04.011

2015-01-01

Abstract:Objective To assess the therapeutic effect and safety of double dose valsartan on hypertension complicated with microalbuminuria in elderly patients. Methods Eighty-nine elderly hypertensive patients complicated with microalbuminuria were randomly divided into control group( n = 48) and treatment group( n = 41),whose blood pressure were not up to standard by single drug. The control group was treated with valsartan 80 mg / d + amlodipine 5 mg / d,and the treatment group was treated with valsartan 160 mg / d for 12 weeks. The blood pressure,24 h uric microalbuminuria,function of liver and kidney,electrolyte were observed before and after treatment. Results After follow-up of 12 weeks,in the control group,blood pressure control rate was 83. 33%,and the level of 24 h uric microalbuminuria decreased from( 115. 20 ± 12. 32) mg/24 h to( 53. 79 ± 9. 35) mg/24 h( P < 0. 05); In the treatment group,blood pressure control rate was 85. 37%,and the level of 24 h urinary protein decreased from( 118. 81 ± 10. 27) mg /24 h to( 51. 75 ± 8. 49)mg /24 h( P < 0. 05). There was no significant difference in blood pressure control rate and the level of uric microalbuminuria after treatment between the two groups( P > 0. 05). There were no significant differences in the levels of urea nitrogen,serum creatinine,cystatin,electrolytes before and after treatment between two groups. Conclusions Double dose of valsartan,as well as amlodipine combined with valsartan not only decreases blood pressure,but also significantly reduces the level of uric microalbuminuria on hypertension complicated with microalbuminuria in elderly patients,with no significant adverse reactions.